Animal Vaccine Market
Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)
Industry Overview
Animal vaccine market was valued at $12,306.8 million in 2025 and is projected to reach $23,604.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The global animal vaccine market is advancing as livestock producers, veterinary healthcare providers, and companion animal owners intensify their focus on preventive healthcare and biosecurity management. Growth is being reinforced by the rising incidence of zoonotic and transboundary animal diseases, alongside increasing demand for high-quality animal protein worldwide. Expanding immunization programs in commercial poultry, swine, and cattle operations are strengthening adoption of advanced vaccine formulations. Technological progress in recombinant and vector-based vaccines is further enhancing efficacy and safety profiles. As regulatory authorities emphasize disease surveillance and herd health management, vaccination is becoming a central pillar in modern animal production systems.
Market Dynamics
Rising Focus on Preventive Veterinary Healthcare Across Livestock and Companion Animals
Animal health stakeholders are increasingly prioritizing preventive immunization to reduce disease outbreaks and production losses. Commercial livestock operations are adopting structured vaccination schedules to maintain herd immunity and improve productivity metrics such as feed conversion ratios and mortality reduction. Companion animal vaccination rates are also rising due to growing pet ownership and heightened awareness of routine veterinary care. Government-led disease control programs and public–private vaccination initiatives are further supporting uptake in emerging economies. As biosecurity standards tighten globally, preventive vaccination strategies are becoming integral to sustainable animal health management.
Technological Advancements in Vaccine Development and Manufacturing
Innovation in vaccine platforms is reshaping the animal vaccine landscape. Recombinant, DNA-based, and vector vaccines are gaining traction due to improved safety, stability, and targeted immune response. Manufacturers are investing in scalable production technologies to meet growing demand across poultry, aquaculture, and livestock segments. Advancements in cold-chain logistics and thermostable formulations are also improving distribution efficiency in remote and developing regions. Additionally, integration of genomics and epidemiological data is enabling faster identification of emerging pathogens and development of customized vaccine solutions. These technological shifts are strengthening product pipelines and enhancing overall market competitiveness.
Market Segmentation
- Based on the type, the market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines, and other animal vaccines.
- Based on the technology, the market is segmented into live attenuated vaccine, killed/inactive vaccine, recombinant vaccine, vectored vaccine, subunit vaccine, DNA vaccine, chimeric vaccine, and others.
Poultry Vaccines Segment to Dominate the Market with the Largest Share
In the global animal vaccine market, the poultry vaccines segment is expected to account for the largest market share, driven by the rapid expansion of the commercial poultry industry and the high susceptibility of poultry to infectious diseases such as avian influenza, Newcastle disease, and infectious bronchitis. Rising global demand for poultry meat and eggs, particularly in emerging economies, has increased the focus on disease prevention to minimize economic losses and ensure food security. Intensive farming practices and high stocking densities further elevate the risk of disease outbreaks, thereby strengthening the need for routine and preventive vaccination programs. In addition, strong government initiatives to control transboundary animal diseases, along with improved biosecurity standards and integration of advanced vaccination schedules in commercial poultry operations, are accelerating vaccine adoption. Continuous advancements in combination vaccines, thermostable formulations, and mass vaccination techniques such as spray and in-ovo vaccination are further enhancing coverage and operational efficiency. These factors collectively reinforce the poultry vaccines segment’s leading position within the overall animal vaccine market.
Live Attenuated Vaccines: A Key Segment in Market Growth
The live attenuated vaccine segment plays a pivotal role in driving growth within the global animal vaccine market, owing to its ability to provide strong and long-lasting immunity with fewer doses. These vaccines closely mimic natural infection, thereby stimulating robust cellular and humoral immune responses in animals. Their widespread use in poultry, livestock, and aquaculture vaccination programs has contributed significantly to market expansion. Moreover, live attenuated vaccines are often cost-effective and suitable for mass immunization campaigns, particularly in large-scale commercial farming systems. Increasing awareness among farmers regarding preventive animal healthcare, coupled with rising investments in veterinary infrastructure and research, is supporting the continued adoption of this technology. Ongoing innovations aimed at improving safety profiles and thermal stability are further strengthening their market presence. Together, these factors highlight the live attenuated vaccine segment as a primary contributor to overall market growth.
Regional Outlook
The global animal vaccine market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Expanding Livestock Immunization Programs Across Asia-Pacific
Asia-Pacific is witnessing robust expansion in the animal vaccine market as countries strengthen livestock disease surveillance and protein production capabilities. Rapid growth in poultry and swine farming, particularly in developing economies, is driving demand for routine immunization programs. Regional authorities are implementing stricter biosecurity frameworks to mitigate economic losses caused by outbreaks such as avian influenza and African swine fever. Investments in veterinary infrastructure and domestic vaccine manufacturing capacity are further supporting market growth. With rising awareness of food safety and export compliance requirements, the region is emerging as a high-potential market for advanced veterinary vaccines.
North America Region Dominates the Market with Major Share
North America holds a significant share in the global animal vaccine market, supported by a well-established veterinary healthcare ecosystem and advanced livestock management practices. The presence of major animal health companies and continuous R&D investments contributes to the steady introduction of innovative vaccine technologies. High adoption rates of companion animal vaccination and structured herd health programs in commercial farming further strengthen regional demand. Government oversight and strict regulatory standards for disease control also encourage routine immunization practices. Together, these factors sustain North America’s leading market position.
Market Players Outlook
The major companies operating in the global animal vaccine market include Elanco Animal Health Incorporated, Merck & Co., Inc., Virbac S.A., Zoetis Inc., Phibro Animal Health Corporation. among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In July 2025, Zoetis Inc. announced the expansion of its poultry vaccine manufacturing facility to increase production capacity and support rising global demand for avian disease prevention solutions.
- In May 2025, Merck Animal Health introduced an advanced recombinant vaccine platform aimed at improving immune response in swine and cattle, reinforcing its commitment to innovation in preventive veterinary medicine.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global animal vaccine Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Animal Vaccine Market Sales Analysis – Type | Technology ($ Million)
- Animal Vaccine Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Animal Vaccine Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Animal Vaccine Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Animal Vaccine Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Animal Vaccine Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Animal Vaccine Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Animal Vaccine Market Revenue and Share by Manufacturers
- Animal Vaccine Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Elanco Animal Health Incorporated
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Virbac S.A.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zoetis Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Phibro Animal Health Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Elanco Animal Health Incorporated
- Key Company Analysis
- Global Animal Vaccine Market Sales Analysis by Type ($ Million)
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Aquaculture Vaccines
- Companion Animal Vaccines
- Other
- Global Animal Vaccine Market Sales Analysis by Technology ($ Million)
- Live Attenuated Vaccine
- Killed/Inactive Vaccine
- Recombinant Vaccine
- Vectored Vaccine
- Subunit Vaccine
- DNA Vaccine
- Chimeric Vaccine
- Others
- Regional Analysis
- North American Animal Vaccine Market Sales Analysis – Type | Technology | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Animal Vaccine Market Sales Analysis – Type | Technology | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Animal Vaccine Market Sales Analysis – Type | Technology | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Animal Vaccine Market Sales Analysis – Type | Technology | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Bharat Biotech International Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biogénesis Bagó S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim International GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Brilliant Bio Pharma Private Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceva Santé Animale
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- China Animal Husbandry Industry Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dechra Pharmaceuticals PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Elanco Animal Health Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hester Biosciences Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HIPRA, S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- IDT Biologika GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Indian Immunologicals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neogen Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Phibro Animal Health Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SeQuent Scientific Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tianjin Ringpu Bio-Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vetoquinol S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Virbac S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zoetis Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bharat Biotech International Limited
1. Global Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Porcine Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Poultry Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Livestock Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Aquaculture Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Companion Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Other Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
9. Global Live Attenuated Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Killed/Inactivated Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Recombinant Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Vectored Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Subunit Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global DNA Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Chimeric Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Others Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
18. North American Animal Vaccine Market Research and Analysis by Country, 2025–2035 ($ Million)
19. North American Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
20. North American Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
21. European Animal Vaccine Market Research and Analysis by Country, 2025–2035 ($ Million)
22. European Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
23. European Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
24. Asia-Pacific Animal Vaccine Market Research and Analysis by Country, 2025–2035 ($ Million)
25. Asia-Pacific Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
26. Asia-Pacific Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
27. Rest of the World Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
28. Rest of the World Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
29. Rest of the World Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
1. Global Animal Vaccine Market Share by Type, 2025 Vs 2035 (%)
2. Global Porcine Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
3. Global Poultry Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
4. Global Livestock Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
5. Global Aquaculture Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
6. Global Companion Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
7. Global Other Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
8. Global Animal Vaccine Market Research and Analysis by Technology, 2025 Vs 2035 (%)
9. Global Live Attenuated Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
10. Global Killed/Inactivated Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
11. Global Recombinant Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
12. Global Vectored Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
13. Global Subunit Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
14. Global DNA Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
15. Global Chimeric Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
16. Global Others Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
17. Global Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
18. US Animal Vaccine Market Size, 2025–2035 ($ Million)
19. Canada Animal Vaccine Market Size, 2025–2035 ($ Million)
20. UK Animal Vaccine Market Size, 2025–2035 ($ Million)
21. France Animal Vaccine Market Size, 2025–2035 ($ Million)
22. Germany Animal Vaccine Market Size, 2025–2035 ($ Million)
23. Italy Animal Vaccine Market Size, 2025–2035 ($ Million)
24. Spain Animal Vaccine Market Size, 2025–2035 ($ Million)
25. Russia Animal Vaccine Market Size, 2025–2035 ($ Million)
26. Rest of Europe Animal Vaccine Market Size, 2025–2035 ($ Million)
27. India Animal Vaccine Market Size, 2025–2035 ($ Million)
28. China Animal Vaccine Market Size, 2025–2035 ($ Million)
29. Japan Animal Vaccine Market Size, 2025–2035 ($ Million)
30. South Korea Animal Vaccine Market Size, 2025–2035 ($ Million)
31. Australia and New Zealand Animal Vaccine Market Size, 2025–2035 ($ Million)
32. ASEAN Economies Animal Vaccine Market Size, 2025–2035 ($ Million)
33. Rest of Asia-Pacific Animal Vaccine Market Size, 2025–2035 ($ Million)
34. Latin America Animal Vaccine Market Size, 2025–2035 ($ Million)
35. Middle East and Africa Animal Vaccine Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Animal Vaccine Market in 2025 is estimated to be around $12,306.8 million.
North America holds the largest share in the Animal Vaccine Market.
Leading players in the Animal Vaccine Market Include Elanco Animal Health Incorporated, Merck & Co., Inc., Virbac S.A., Zoetis Inc., Phibro Animal Health Corporation. among others.
The Animal Vaccine Market is expected to grow at a CAGR of 6.8% from 2026 to 2035.
The Animal Vaccine market growth is driven by increasing prevalence of animal diseases, rising pet ownership, and growing demand for livestock health management.
